My clinical expertise and research interests are concentrated in the field of lymphoid malignancies (i.e., Hodgkin lymphoma and non-Hodgkin lymphoma). Over the past 20 years, I have been the principal investigator of more than 100 cancer clinical trials that have included phase I, II, and III studies, many of which have been “investigator-initiated” studies examining new and novel targeted agents. Collectively, my research has been continuously funded by the National Institutes of Health (NIH) since 2005, which includes several global collaborations I help lead. This has resulted in 350+ research abstract presentations at national and international cancer symposiums, 200+ manuscripts in peer-reviewed publications, and 40+ book chapters with an emphasis on the prognosis, treatment, and health outcomes of cancer.